Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Waltham, Massachusetts
- Most recent report
- 8-K, filed Sep 8, 2026
- Incorporated
- Delaware
- Filings on record
- 810 filings
- On EDGAR
- CIK 1636282
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 47
News 8 of 171
Prospectuses and Registrations 8 of 75
- S-3ASR Automatic shelf registration Jun 26, 2026
- 424B5 Prospectus supplement for an offering Apr 16, 2026
- 424B5 Prospectus supplement for an offering Apr 13, 2026
- POS AM Post-effective amendment to a registration Feb 27, 2026
- S-3 Shelf registration statement Feb 19, 2026
- S-8 Registration statement for an employee plan Feb 19, 2026
- 424B5 Prospectus supplement for an offering Oct 14, 2025
- 424B5 Prospectus supplement for an offering Oct 14, 2025
Proxies 8 of 19
- DEFA14A Extra proxy material Apr 10, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 10, 2026
- DEFA14A Extra proxy material Apr 14, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 1, 2024
- PRE 14A Preliminary proxy statement Mar 20, 2024
- DEF 14A Proxy statement for a shareholder vote Oct 27, 2023
- PRE 14A Preliminary proxy statement Aug 8, 2023
Ownership 8 of 410
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 144 Notice of a proposed sale of restricted stock Sep 1, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- 4 Insider reported a trade Aug 10, 2026
- 144 Notice of a proposed sale of restricted stock Aug 7, 2026
Other 8 of 88
- ARS Annual report sent to shareholders Apr 10, 2026
- EFFECT Notice that a registration became effective Mar 4, 2026
- EFFECT Notice that a registration became effective Feb 27, 2026
- CORRESP Reply to SEC staff Feb 25, 2026
- UPLOAD Comment letter from SEC staff Feb 25, 2026
- UPLOAD Comment letter from SEC staff Jun 2, 2025
- CORRESP Reply to SEC staff May 21, 2025
- UPLOAD Comment letter from SEC staff May 9, 2025
Everything here comes from Spyre Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.